Your session is about to expire
← Back to Search
Navigation Services for COVID-19
N/A
Waitlist Available
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within one week of the intervention session
Awards & highlights
Study Summary
This trial will test an adaptation of an HIV prevention & care framework to see if it can be used to track COVID-19 testing & follow-up in a vulnerable population. It'll use an collaborative research framework that includes community members & service providers to optimize the intervention.
Eligible Conditions
- COVID-19
- Coronavirus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within one week of the intervention session
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within one week of the intervention session
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Completion of COVID-19 test
Trial Design
8Treatment groups
Experimental Treatment
Group I: Referral/tested/brochureExperimental Treatment1 Intervention
After initial randomization, some participants will be assigned to receive standard referral services. Those who complete the COVID-19 testing will again be randomized and some will receive a digital brochure.
Group II: Referral/tested/brief counselingExperimental Treatment1 Intervention
After initial randomization, some participants will be assigned to receive standard referral services. Those who complete the COVID-19 testing will again be randomized and some will be assigned to receive Brief Counseling (BC).
Group III: Referral/not tested/critical dialogueExperimental Treatment1 Intervention
After initial randomization, some participants will be assigned to receive standard referral services. Those who do not complete the COVID-19 testing will again be randomized and some will be assigned to Critical Dialogue (CD).
Group IV: Referral/not tested/brochureExperimental Treatment1 Intervention
After initial randomization, some participants will be assigned to receive standard referral services. Those who do not complete the COVID-19 testing will again be randomized and some will receive a digital brochure.
Group V: Navigation/tested/navigation servicesExperimental Treatment1 Intervention
After initial randomization, some participants will be assigned to receive navigation services(NS). Those who complete the COVID-19 testing will again be randomized and some will continue receiving NS.
Group VI: Navigation/tested/brief counselingExperimental Treatment2 Interventions
After initial randomization, some participants will be assigned to receive navigation services (NS). Those who complete the COVID-19 testing will again be randomized and some will be assigned to receive Brief Counseling (BC)
Group VII: Navigation/not tested/navigation servicesExperimental Treatment1 Intervention
After initial randomization, some participants will be assigned to receive navigation services (NS). Those who do not complete the COVID-19 testing will again be randomized and some will continue receiving NS.
Group VIII: Navigation/not tested/critical dialogueExperimental Treatment2 Interventions
After initial randomization, some participants will be assigned to receive navigation services(NS). Those who do not complete the COVID-19 testing will again be randomized and some will be assigned to Critical Dialogue (CD)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Navigation Services
2021
N/A
~3030
Brief Counseling
2021
N/A
~1230
Critical Dialogue
2021
N/A
~1830
Referral and Digital Brochure
2021
N/A
~1230
Find a Location
Who is running the clinical trial?
North Jersey Community Research InitiativeUNKNOWN
3 Previous Clinical Trials
1,335 Total Patients Enrolled
1 Trials studying COVID-19
668 Patients Enrolled for COVID-19
University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
36,781 Total Patients Enrolled
3 Trials studying COVID-19
1,588 Patients Enrolled for COVID-19
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,268 Previous Clinical Trials
5,480,578 Total Patients Enrolled
78 Trials studying COVID-19
291,654 Patients Enrolled for COVID-19
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You do not know how to speak English.You have a higher chance of getting COVID-19 or experiencing severe symptoms if you get it.You are at low risk for catching COVID-19 or having severe symptoms if you do catch it.You can communicate effectively in English.
Research Study Groups:
This trial has the following groups:- Group 1: Referral/not tested/critical dialogue
- Group 2: Navigation/tested/navigation services
- Group 3: Navigation/tested/brief counseling
- Group 4: Navigation/not tested/navigation services
- Group 5: Navigation/not tested/critical dialogue
- Group 6: Referral/tested/brochure
- Group 7: Referral/tested/brief counseling
- Group 8: Referral/not tested/brochure
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many individuals have chosen to participate in this experimental research?
"Affirmative. As shown on clinicaltrials.gov, the trial which was initially posted on April 4th 2022 is actively seeking participants. This research requires 548 patients from 1 site to participate in this project before it can be considered complete."
Answered by AI
Are there vacancies in the trial for participants?
"Affirmative. According to the clinicaltrials.gov page, this medical study is open for recruitment starting on April 4th 2022 and was most recently updated on July 12th 2022. This trial necessitates 548 participants from a single healthcare facility."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger